Imricor Medical Systems, Inc. (ASX:IMR)

Imricor Medical Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	60.54	19.5	15.71	0.83	5.69	18.52
Short-Term Investments	6.92	21.28	-	-	-	-
Cash & Short-Term Investments	67.46	40.78	15.71	0.83	5.69	18.52
Cash Growth	34.00%	159.62%	1789.04%	-85.38%	-69.28%	-26.35%
Receivables	0.31	0.24	0.35	0.39	0.13	0.09
Inventory	1.35	1.1	1.5	1.68	2.28	2.58
Prepaid Expenses	0.58	0.8	0.79	1.03	1.59	1.51
Total Current Assets	69.7	42.92	18.35	3.94	9.68	22.7
Property, Plant & Equipment	2.62	2.14	2.6	3.17	3.56	3.6
Other Long-Term Assets	1.27	0.7	0.68	1.2	0.46	0.57
Total Assets	73.59	45.76	21.62	8.31	13.7	26.86

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.19	0.5	0.33	2.1	0.26	0.69
Accrued Expenses	1.59	1.62	1.49	0.79	0.92	1.35
Short-Term Debt	-	-	-	0.36	-	-
Current Portion of Long-Term Debt	33.19	11.75	-	-	-	-
Current Portion of Leases	0.31	0.32	0.47	0.73	0.87	0.52
Current Unearned Revenue	0.03	0.03	0.06	0.58	0.02	0.18
Other Current Liabilities	4.29	3.16	-	-	-	-
Total Current Liabilities	40.59	17.37	2.36	4.57	2.07	2.74
Long-Term Debt	-	13.27	19.87	8.49	2.18	-
Long-Term Leases	0.52	0.63	0.88	1.14	1.4	1.22
Long-Term Unearned Revenue	1.09	1.09	1.1	0.79	0.49	0.51
Other Long-Term Liabilities	2.32	1.87	4.8	2.08	0.04	-
Total Liabilities	44.52	34.23	29	17.06	6.19	4.46

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.04	0.03	0.03	0.02	0.02	0.01
Additional Paid-In Capital	221.77	179.09	134.88	103.82	97.46	94.99
Retained Earnings	-192.74	-167.6	-142.28	-112.59	-89.96	-72.6
Shareholders' Equity	29.07	11.52	-7.38	-8.75	7.51	22.4
Total Liabilities & Equity	73.59	45.76	21.62	8.31	13.7	26.86

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	34.02	25.97	21.21	10.71	4.45	1.74
Net Cash (Debt)	33.44	14.81	-5.51	-9.88	1.24	16.78
Net Cash Growth	30.94%	-	-	-	-92.60%	-25.90%
Net Cash Per Share	0.10	0.05	-0.02	-0.06	0.01	0.13
Filing Date Shares Outstanding	358.57	320.95	270.18	168.92	151.35	143.23
Total Common Shares Outstanding	353.49	320.95	270.18	168.92	151.35	143.23
Working Capital	29.11	25.55	15.99	-0.63	7.61	19.96
Book Value Per Share	0.08	0.04	-0.03	-0.05	0.05	0.16
Tangible Book Value	29.07	11.52	-7.38	-8.75	7.51	22.4
Tangible Book Value Per Share	0.08	0.04	-0.03	-0.05	0.05	0.16
Machinery	5.27	4.4	4.11	3.84	3.47	3.28
Leasehold Improvements	1.64	1.64	1.64	1.64	1.64	1.6

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error